A detailed history of Cornerstone Investment Partners, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Cornerstone Investment Partners, LLC holds 5,944 shares of CORT stock, worth $333,398. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,944
Holding current value
$333,398
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$29.51 - $46.26 $175,407 - $274,969
5,944 New
5,944 $274,000
Q4 2023

Jan 31, 2024

BUY
$24.82 - $32.88 $154,703 - $204,941
6,233 New
6,233 $202,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.01B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Cornerstone Investment Partners, LLC Portfolio

Follow Cornerstone Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Investment Partners, LLC with notifications on news.